Wegovy is the weight-loss face of a molecule you already know. That single fact answers most of the "Wegovy generic" question before the patents even come up.
Direct answer: No. There is no FDA-approved generic Wegovy in 2026. Wegovy's active ingredient is semaglutide — the exact same molecule inside Ozempic, just dosed and labeled for chronic weight management. Because it's the same drug, it sits behind the same patent wall: the core semaglutide compound patent runs to December 2031, so a US generic isn't realistically arriving until around 2032. What does exist right now is a set of "generic-price" routes — most notably the $149/month oral Wegovy pill at its starter dose and the $349/month NovoCare cash price on the injection. Those are not generics, but they're the cheapest legitimate ways to get FDA-approved semaglutide today.
Wegovy generic status at a glance
| Question | Answer (June 2026) |
|---|---|
| Is there an FDA-approved generic Wegovy? | No |
| What is Wegovy's generic name? | Semaglutide |
| Same molecule as Ozempic? | Yes — different dose and label |
| Cheapest FDA-approved route now | Oral Wegovy pill, $149/month starter dose |
| Cheapest injectable cash route | NovoCare self-pay, ~$349/month |
| Likely US generic year | ~2032 |
The generic name is semaglutide (and it's literally Ozempic's molecule)
If you've read that Ozempic and Wegovy are "basically the same," that's because they are. Both are semaglutide, a GLP-1 receptor agonist. Ozempic is approved for type 2 diabetes and tops out at 2 mg per week; Wegovy is approved for weight management and goes to 2.4 mg per week. So the "generic name for Wegovy" is the same answer as for Ozempic: semaglutide. A future generic semaglutide injection would, in practice, be a generic for both — which is exactly why Novo Nordisk fights so hard to hold the patents.
Why there's no generic: the patent timeline
Wegovy inherits semaglutide's patent protection. The molecule doesn't go off-patent just because the label says "weight loss."
| Protection | What it blocks | US timing |
|---|---|---|
| Semaglutide compound patent ('343) | Any generic semaglutide injection | December 2031 |
| Method-of-use patents | Specific labeled uses | 2033 and beyond |
| Broader formulation portfolio | Oral and device variants | Out to ~2040 |
| Practical generic entry | First licensed generic launch | ~2032 |
In fall 2024, Novo Nordisk settled with generic challengers (Mylan, Dr. Reddy's, Apotex, Sun Pharmaceuticals) on confidential terms, and Markman Advisors reads the landscape as pointing to generic entry around 2032. A generic Ozempic arriving then would let prescribers write off-label for weight loss, which is expected to erode Wegovy's monopoly even before a dedicated Wegovy generic exists.
The practical "generic price" right now: the $149 pill and $349 cash
Here's the good news the patent story hides. You don't need a generic to pay far less than the ~$1,300 list price.
| Route | What it is | Cash price |
|---|---|---|
| Oral Wegovy pill, starter dose | Once-daily semaglutide tablet (1.5 mg / 4 mg) | $149/month |
| Oral Wegovy pill, higher doses | 9 mg / 25 mg tablets | $299/month |
| Injectable Wegovy via NovoCare | Self-pay direct from Novo Nordisk | $349/month (1, 1.7, 2.4 mg) |
| Savings card (commercial insurance) | Copay assistance | As low as $0-25/month if eligible |
| Doctor-supervised compounded semaglutide | Licensed US pharmacy, telehealth | From ~$146/month |
The oral pill is the headline. Novo Nordisk's once-daily oral semaglutide launched in early 2026 as the first weight-loss GLP-1 in pill form, and the starter dose came in at $149/month for cash-paying patients (the 9 mg and 25 mg strengths run $299). For people who just want effective semaglutide at a non-brutal price, that pill is the closest thing to a "generic price" on the market — see our Wegovy pill cost breakdown. The injectable NovoCare cash price of $349/month is the other big lever.
Want the generic price without the wait? Yücca telehealth — online evaluation, doctor-prescribed compounded Semaglutide+ or Tirzepatide+ filled by a licensed US pharmacy, from $146/month. (Partner link: we may earn a commission, at no extra cost to you.)
What about compounded Wegovy?
There's no such thing as "compounded Wegovy" as an FDA-approved product, and compounded semaglutide is not a generic. The FDA declared the semaglutide shortage resolved in February 2025, ending the broad compounding exception, and on April 30, 2026 it proposed barring outsourcing facilities from compounding semaglutide from bulk at all, with comments open through June 29, 2026. Doctor-supervised compounding through a licensed pharmacy still exists as a regulated route for now, but it should never be confused with a bioequivalent, FDA-approved generic. The practical takeaway: don't wait for a "generic Wegovy" that's years away, and don't gamble on gray-market vials. Between the oral pill, the NovoCare cash price, savings cards, and supervised compounding, there are already four legitimate ways to pay far below the brand list price for the same molecule.
For more savings paths, see our Wegovy coupon guide and the cheapest GLP-1 roundup. The diabetes-label sibling is covered on the Ozempic generic page; the oral tablet's longer patents are on the Rybelsus generic page; and the full molecule timeline lives on the generic semaglutide hub.
Frequently asked questions
Is there a generic version of Wegovy? No. No FDA-approved generic Wegovy exists in 2026, and the earliest realistic US launch is around 2032 when the semaglutide compound patent expires.
What is the generic name of Wegovy? Semaglutide — the same active ingredient as Ozempic, dosed up to 2.4 mg weekly for weight management.
What's the cheapest legitimate way to get Wegovy now? The oral Wegovy pill at $149/month for the starter dose, or the injectable at $349/month through NovoCare self-pay. Eligible commercially-insured patients can pay even less with a savings card.
Will generic Ozempic count as generic Wegovy? Functionally close. A generic semaglutide injection could be prescribed off-label for weight loss, which would undercut Wegovy even before a Wegovy-labeled generic exists.
Is the oral Wegovy pill a generic? No — it's a brand product. It's just priced far below the injectable list price, which is why it functions as the practical "generic-price" option.
Last reviewed: June 13, 2026
Sources
- What is the patent landscape for Novo Nordisk's semaglutide products? — Markman Advisors
- Wegovy Pill Cost in 2026: With and Without Insurance — Noom
- Apotex Wins First Tentative FDA Approval for Generic Semaglutide Injection — Prism News
- FDA Moves to Permanently Close the Door on Compounded GLP-1s — Pharmacy Times
